Rajiv Agarwal

75PUBLICATIONS
143CO-AUTHORS
Molecular medicineCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (75)

|Sep 02, 2026
PRO/CON debate: nonsteroidal versus steroidal mineralocorticoid receptor antagonists in chronic kidney disease: progress, pragmatism, and remaining uncertainties.

|Aug 30, 2026
Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

|Aug 18, 2026
Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis.

|Aug 08, 2026
Individualizing pharmacologic and non-pharmacologic therapy for CKD associated with diabetes.

|Jun 26, 2026
Systolic blood pressure and albuminuria reduction mediate cardiovascular benefits of finerenone in T2 diabetes and CKD.

|Jun 15, 2026
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.

Pageof 13

Frequent Collaborators

20 joint publications

Peter Rossing

18 joint publications

Hiddo J L Heerspink

14 joint publications

Muthiah Vaduganathan

11 joint publications

George L Bakris